ASRS
TSHA icon

Arizona State Retirement System’s Taysha Gene Therapies TSHA Stock Holding History

Arizona State Retirement System’s Portfolio TSHA Stock Details TSHA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$270K Buy
39,633
+2,014
+5% +$11.9K ﹤0.01% 1847
2026
Q1 		$168K Sell
37,619
-58
-0.2% -$270 ﹤0.01% 1947
2025
Q4 		$207K Buy
+37,677
New +$183K ﹤0.01% 1904

Other funds holding TSHA

ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Arizona State Retirement System's TSHA Position: Q2 2026 in Review

Arizona State Retirement System increased its Taysha Gene Therapies (TSHA) stake by 5.4% in Q2 2026, buying an estimated $11.9K and bringing the position to 39,633 shares worth $270K. The position accounts for ﹤0.01% of the portfolio, ranked #1847.

Arizona State Retirement System first reported a position in TSHA in Q4 2025 and has held it in 3 quarters since. 209 funds tracked by Wall St. Rank hold TSHA as of Q2 2026.

  • Arizona State Retirement System held 39,633 shares of Taysha Gene Therapies worth $270K as of Q2 2026.
  • Arizona State Retirement System bought 2,014 Taysha Gene Therapies shares in Q2 2026, an estimated $11.9K.
  • Taysha Gene Therapies made up ﹤0.01% of Arizona State Retirement System's portfolio in Q2 2026, its #1847 holding.
  • Arizona State Retirement System first reported a position in Taysha Gene Therapies in Q4 2025 and has held it in 3 quarters since.
  • 209 funds tracked by Wall St. Rank held Taysha Gene Therapies as of Q2 2026.

Based on Arizona State Retirement System's 13F filing for Q2 2026, filed 7 Aug 2026.